Info

HBT-39b (carcinoma,

P. Arnstein from E. Plata

breast) (clone 6)

breast) (clone 6)

TABLE II (Continued)

Designation

Source

HEK (kidney)

HEK/HRV (HEK, virus transformed) MA160 (prostate) MA 160

Prostate (= MA 160) SA4 (TxS-HuSa, Xliposar-

coma) SA4

RT4 (carcinoma, bladder) Detroit 30A (carcinoma, ascitic fluid) Detroit 98 (=CCL18-(ster-

nal marrow) Detroit 98s (=CCL18.1) Detroit 98/AG (CCL18.2) Detroit 98AT-2 (=CCL18.3) Detroit 98/AHR

(=CCL18.4) FL (=CCL62) (amnion) CaOV (carcinoma, ovary) J96 (leukemic blood) Jill (monocytic leukemia) (=CCL24)

T-9 (transformed normal diploid) DAPT (astrocytoma, piloid) AO (amnion)

KP-P, (carcinoma, prostate) EICo (carcinoma, breast) HCE (carcinoma, cervix) CMP (adenocarcinoma, rectum) CMPIIC2 JHT (placenta) OE (endometrium)

SH-2 (carcinoma, breast)

SH-3 (carcinoma, breast)

Commercial, unlisted J. Rhim from C. Pfizer, Inc. C. Pfizer, Inc. S. Aaronson

The originators P. Price, MBA M. Vincent, MBA Unlisted

D. Morton

0 0

Post a comment